Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Thrombin inhibitors developed by Merck scientists

May 13, 1999

Yamanouchi describes novel series of factor Xa inhibitors

May 10, 1999

Kissei develops new anticoagulants acting selectively against factor Xa

May 7, 1999

Glaxo Wellcome dicloses novel class of serine protease inhibitors

May 6, 1999

Antithrombotic agents synthesized and tested at Roche

May 5, 1999

Inhibitors of factor Xa recently disclosed by DuPont

May 3, 1999

Orally active fibrinogen antagonist developed by Merck

May 3, 1999

Potent and selective small-molecule thrombin inhibitor developed at DuPont

April 30, 1999

Definitive copromotion agreement for cilostazol signed by Otsuka and Pharmacia & Upjohn

April 29, 1999

Aggrenox unanimously recommended for approval for stroke indication

April 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...